| HAZARDOUS DRUGS RELATED ARTICLES |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom
Kastango Eric S, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura
|
Sep/Oct 2024
Pg. 383-393
|
Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom
Kastango Eric S, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura
|
Jan/Feb 2024
Pg. 44-55
|
Testosterone 2-mg and Dehydroepiandrosterone (DHEA) 15-mg Troches
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 65
|
Primary Engineering Controls in Pharmaceutical Compounding, Part 2: Biosafety Cabinets
Mulder Kyle
|
Jan/Feb 2020
Pg. 7-12
|
Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk
Cabaleiro Joe
|
Jan/Feb 2020
Pg. 21-27
|
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Dillon L R
|
Jan/Feb 2020
Pg. 30-36
|
Primary Engineering Controls in Pharmaceutical Compounding, Part 1: Unidirectional-airflow Workstations, Compounding Aseptic Isolators, and Compounding Aseptic Containment Isolators
Mulder Kyle
|
Nov/Dec 2019
Pg. 447-452
|
Evaluation of Containment Ventilated Enclosure Performance in Absence of Negative Pressure Containment Secondary Engineering Control
Hutson Chad, Day A J
|
Nov/Dec 2019
Pg. 511-518
|
Compounded Cyclophosphamide and Piroxicam for the Treatment of a Canine Peripheral Nerve Sheath Tumor: A Case Report
Pope George, Daleo Charles, Batson SL
|
Sep/Oct 2019
Pg. 358-364
|
Contamination Control in Compounding Areas
Mulder Kyle, Gonzales Ben A
|
Jul/Aug 2019
Pg. 271-278
|
How to Develop and Maintain a Hazardous Drug List
Dillon L Rad
|
May/Jun 2019
Pg. 182-186
|
Basics of Compounding for Sterile, Nonsterile, and Quality Control Compounding: Process Analytical Technology: Appropriate for Sterile and Nonsterile Compounding?
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 123-130
|
Certification of Powder-containment Hoods for Nonsterile Compounding
Mulder Kyle, Dozzi Raphael
|
Sep/Oct 2018
Pg. 369-384
|
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Ashe Krystina, Baskett Dustin
|
Sep/Oct 2018
Pg. 387-398
|
Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags
Breukels Oscar, van der Gronde Toon, Simons-Sanders Kathleen, Crul Mirjam
|
Jul/Aug 2018
Pg. 345-349
|
Trace Level Analysis of Airborne Hormone Particulates
Trimble John O, Hampton Shanna
|
May/Jun 2018
Pg. 257-263
|
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 356
|
PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives
Allen Loyd V Jr
|
May/Jun 2017
Pg. 180
|
Quality Control: (Material) Safety Data Sheets
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 118-124
|
Bosentan 6.25-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 505
|
Erlotinib 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 508
|
Imatinib 40-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 510
|
PreScription: Patient Access to Pharmaceuticals
Allen Loyd V Jr
|
May/Jun 2016
Pg. 180
|
Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal)
Garrigue Philippe, Montana Marc, Ventre Christophe, Savry Amadine, Gauthier-Villano Laurence, Pisano Pascale, Pourroy Bertrand
|
Mar/Apr 2016
Pg. 148-154
|
Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom
Kastango Eric S, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura
|
Jul/Aug 2015
Pg. 268-278
|
Quality Control Analytical Methods: Establishing Powder-handling Workflow Practices and Standard Operating Procedures: Compounding Pharmacy and Safety
Prince Bryan, Lundevall Jeremy
|
May/Jun 2014
Pg. 222-226
|
A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards
Marks Zach
|
Mar/Apr 2014
Pg. 94-99
|
Quality Control Analytical Methods: A Growing Codependency: Compounding Pharmacy and Safety
Prince Bryan, Lundeval Jeremy
|
Nov/Dec 2013
Pg. 485-489
|
Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists
Mixon Bill, Nain John
|
May/Jun 2013
Pg. 182-190
|
Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum
Zur Eyal
|
Mar/Apr 2012
Pg. 117-124
|
Preparing Nonsterile and Sterile Hazardous Compounds in an Institutional Setting
McElhiney Linda F
|
Jul/Aug 2009
Pg. 300-310
|
Compounding for Cancer in Companion Animals
Mixon William, Northrup Nicole, Vail Jane
|
Jan/Feb 2009
Pg. 42-49
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs
Allen Loyd V Jr, Okeke Claudia C
|
Jan/Feb 2009
Pg. 56-62
|
Disposing of Expired Drugs and Chemicals: New Options for Compounders
Vail Jane
|
Jan/Feb 2008
Pg. 38-47
View Sample |
PostScription: Consumer Options for Disposal of Unused Medications
Vail Jane
|
Jan/Feb 2008
Pg. 87
|
Basics of Compounding for Hazardous Drugs, Part 4: Developing the Hazardous Drugs List and Containment Workstations
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 149-151
|
Basics of Compounding for Hazardous Drugs, Part 3: Safe Handling and Personal Protection
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 50-51
|
Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 446-448
|
Basics of Compounding for Hazardous Drugs, Part 1: An Introduction
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 377-379
|
Standard Operating Procedure: Labconco Basic 47 Laboratory Hood
Allen Loyd V Jr
|
Mar/Apr 2006
Pg. 135
|
Local Ventilation for Safe Containment in the Pharmaceutical Industry
Walters Douglas B, Ryan Ray
|
Jul/Aug 2005
Pg. 293-298
|
Considerations for Choosing a Primary Engineering Control for Compounding Sterile Products
Wagner James T
|
Jul/Aug 2005
Pg. 284-290
|
Using ACDs in the Practice of Pharmacy
Kastango Eric S
|
Jan/Feb 2005
Pg. 15-21
|
An Ounce of Prevention: Controlling Hazards in Extemporaneous Compounding Practices
Kastango Eric S, Trissel Lawrence A, Bradshaw Brian D
|
Sep/Oct 2003
Pg. 401-416
|
Containment of Hazardous Particulates in the Compounding Pharmacy
Allen Loyd V Jr
|
Jul/Aug 2003
Pg. 281-285
|
Product Containment in the Compounding Laboratory
Vidrine Eric
|
May/Jun 2003
Pg. 213-214
|
Facilities and Procedures for Compounding Hazardous Drugs
Rahe Hank
|
Jul/Aug 2002
Pg. 267-270
|
Compounding Containment Devices: Buyer Be Aware
Kastango Eric S
|
Sep/Oct 2001
Pg. 384-388
|
Sterile Compounding with Barrier-Isolation Technology
Rahe Hank
|
Jul/Aug 2001
Pg. 254-258
|
Compounding Using Hazardous Drugs
Lau Kellie
|
Jul/Aug 2000
Pg. 261-263
|
| Return to Top |
